Interaction of the integrin b3 cytoplasmic tail with kindlin-2 selectively promotes outside-in signaling through aVb3.
Introduction
Integrins are transmembrane receptors composed of a and b subunits that mediate bidirectional signaling between the extracellular matrix and the cell interior. Among the best studied integrins is aIIbb3, which is required for hemostasis and platelet involvement in thrombosis. 1, 2 The related b3 integrin, aVb3, is expressed at low levels in platelets and better expressed in several other hematopoietic cells and in cells of the vasculature, particularly proliferative endothelial cells (ECs). 3 Studies of aVb3 function in vitro and in genetically modified mice appear somewhat contradictory. Antibodies or small molecules that block the binding of vitronectin and other matrix ligands to aVb3 can inhibit aVb3-dependent cell migration and angiogenesis. 4 However, b3 knockout mice show increased tumor growth and angiogenesis, in part from elevated expression of vascular endothelial growth factor receptor-2 (VEGFR-2) in b3 2/2 ECs. 5 Furthermore, acute but not long-term depletion of b3 in ECs inhibits tumor growth and angiogenesis in mice. 6 Global or tissuespecific ablation of b3 may lead to altered expression of nontargeted genes, VEGFR-2 being one example. Generation of knock-in mutations in b3 may avoid this problem, as exemplified by normal VEGFR-2 expression in "b3(DiY.F)" knock-in mice, in which 2 b3 cytoplasmic tail tyrosines (747 and 759) are mutated to phenylalanine, resulting in reduced tumor angiogenesis. 7 This result was attributed to effects on bidirectional integrin signaling and to disruption of normal interactions between aVb3 and VEGFR-2. Thus, further studies of b3 knock-in mice might lead to a deeper understanding of aVb3 function.
Integrin signaling encompasses "inside-out" regulation of adhesive ligand binding to integrins and ligand-dependent "outside-in" regulation of cellular responses. 8 In both contexts, signaling can be influenced by interactions of integrin cytoplasmic tails with specific enzymes and adapters. 8, 9 Among proteins capable of interacting with the b3 cytoplasmic tail are the Src family protein tyrosine kinases (SFKs) and the adapters talin and kindlin. One function of SFKs in platelets and ECs is the phosphorylation of b3 Y747 and Y759, resulting in reduced interaction of b3 with talin 10 and kindlins, 11, 12 respectively. Direct interaction between c-Src and the extreme C terminus of the b3 cytoplasmic tail appears to be required for normal aIIbb3-dependent platelet functions in vivo 13 and for the aVb3dependent functions of stem cells 14 and tumor cells. 15 Consequently, binding of c-Src to the b3 tail in ECs might regulate aVb3 signaling. Indeed, "b3(DiY.F)" knock-in mice with phenylalanine substitutions at the 2 putative SFK phosphorylation sites exhibit reduced angiogenesis. 10, 16 The kindlin family of adapters (kindlin-1, kindlin-2, and kindlin-3) plays key roles in multiple cell types to promote bidirectional signaling involving b1, b2, and b3 integrins. 11, [17] [18] [19] [20] [21] For example, kindlin-3 cooperates with talin to effect b2 activation in leukocytes and b3 activation in platelets. 22, 23 Moreover, interaction between kindlin-3 and b2 integrins seems to be required for T-cell homing in vivo. 24 Kindlin-2 is the predominant isoform in ECs, and kindlin-2 1/2 mice exhibit reduced tumor vessel density and growth, 25 suggesting a role for kindlin-2 in EC functions. However, because kindlins may also function in integrin-independent processes, 26 the extent to which any function of kindlin-2 in ECs is due to its direct interaction with integrin b cytoplasmic tails remains to be determined.
Here we sought to clarify the role of aVb3 signaling in ECs and by so doing shed more light on the molecular underpinnings of aVb3 function. We have taken advantage of 2 b3 knock-in mouse strains with deletion or mutations of the 3 most C-terminal b3 residues (R 760 GT 762 ). 13 Studies of aIIbb3 in murine platelets and in heterologous expression systems have demonstrated that the C-terminal 3 amino acids of the b3 cytoplasmic tail (Arg-Gly-Thr, RGT) are required for b3 interactions with c-Src and certain other SFKs. 13, 27, 28 In addition, residues at or near the C terminus of integrin b tails support tail interaction with kindlins. 11, 18, 19, 29 For example, the last 3 amino acids (Glu-Gly-Lys, EGK) of b1 are required for kindlin-2 interaction 18 ; however, they do not enable c-Src binding to b1. 27 Therefore, we hypothesized that deletion of RGT would prevent normal kindlin-2 binding to b3, whereas substitution of RGT with EGK would enable kindlin-2 binding to b3. By studying ECs as a biologically relevant experimental platform, we have established the differential roles of the b3/kindlin-2 and the b3/c-Src interactions in aVb3 functions. Specifically, the interaction of b3 with kindlin-2, but not with c-Src, is required for outside-in signaling through aVb3, with implications for EC function in vitro and in vivo.
Methods
Reagents, DNA constructs, cell lines, and mice are described in detail in the supplemental Methods on the Blood Web site. All animal procedures were performed using protocols approved by the University of California San Diego Institutional Animal Care and Use Committee.
Western blotting and pull-down assays
Western blotting and pull-down assays using recombinant integrin tails were performed as described elsewhere. [30] [31] [32] [33] 
Cell migration
Transwells with 8-mm pores were coated on both sides with 10 ng/mL vitronectin overnight at 4°C. Then 10 5 immortalized lung ECs (imLECs) in 200 mL of endothelial basal medium were added to the upper chamber and 700 mL of medium (with or without 10% fetal bovine serum) were added to the lower chamber. After 16 hours at 37°C and 5% CO 2 , cells on the upper surface of the chamber were removed with a cotton swab and migrated cells on the lower surface were fixed with methanol at 220°C for 15 minutes and stained with 0.1% crystal violet. Migration was quantified by eluting crystal violet in 10% acetic acid and measuring absorbance at 590 nm.
Detection of aVb3 activation
A ligand-mimetic antibody, WOW-1 Fab, was used to detect activated aVb3 in ECs. 32 For suspended cells, 4-6 3 10 5 imLECs in 50 mL modified Tyrode's buffer were incubated for 30 minutes at 22°C with WOW-1 Fab 6 200 nM phorbol 12,13-dibutyrate (PDBu), a protein kinase C activator. After addition of 50 mg/mL Alexa Fluor 647-labeled F(ab9) 2 fragment of goat anti-mouse immunoglobulin G (H 1 L chains), WOW-1 Fab binding was determined by flow cytometry. Nonspecific binding was determined in the presence of 5 mM EDTA, and specific binding was taken as total minus nonspecific binding. 32 For adherent cells, imLECs were plated on coverslips coated with 25 mg/mL fibrinogen and incubated 6 200 nM PDBu for 1 hour at 37°C. Cells were fixed and permeabilized before staining with WOW-1 Fab and rhodamine-phalloidin for F-actin. 33 Confocal images were acquired using an Olympus FV1000 confocal microscope.
Three-dimensional fibrin gel bead assay
An in vitro model that simulates the process of EC sprouting was used exactly as described. 34, 35 EC sprout formation was quantified by scoring sprouts with lengths greater than the bead diameter and assessed independently by 2 authors in a blinded fashion.
Retinal angiogenesis
Mouse eyes were obtained at postnatal day 3 and onwards by enucleation. After fixation with 2% paraformaldehyde in phosphate-buffered saline (PBS) for 1 hour at 4°C, lens, sclera, cornea, and vitreous were excised and the retina dissected. 36, 37 Tissues were fixed, permeabilized, and stained overnight at 4°C with rat anti-mouse CD31 antibody MEC13.3 (1:100). Retinas were washed in PBS, stained with Alexa Fluor 647-conjugated goat anti-rat secondary antibody and mounted by making 4 incisions in anti-fade mounting medium. Images of retinal vessels were acquired using LSM 5 software on a Zeiss 510 confocal microscope with a 310 oil-objective lens (Nikon) and analyzed with Adobe Photoshop CS4 (Adobe Systems) and ImageJ (NIH). To assess proliferation, retinal endothelium was labeled with fluorescein isothiocyanate-isolectin B4 and stained with rat anti-mouse Ki67. Endothelial tip cells and filopodia per 25 mm of vessel length were quantified in sprouting vascular fronts after photographing at 340 and 3100, respectively, using an Olympus FV1000 confocal microscope and ImageJ.
Pathological angiogenesis b3 1/1 (wild-type; WT), b3 1/2 , b3DRGT, and b3/b1(EGK) mice were inoculated subcutaneously with 2 3 10 5 B16F1 murine melanoma cells in 300 mL PBS. Twenty-one days later, tumors were excised and weighed. Frozen sections were fixed with acetone/4% paraformaldehyde, permeabilized with 0.1% Triton X-100 in PBS, blocked with 10% goat serum, and stained with anti-mouse CD31, appropriate secondary antibody, and with Hoechst 33342 for nuclei. Images were acquired using a PlanFluor 310 objective and an Eclipse TE2000-U microscopy system (Nikon). The area of CD31-positive blood vessels was quantified by calculating mean positive pixels from $9 representative images of each tumor using MATLAB software. 7
Bone marrow transplantation
Bone marrow was harvested from euthanized donor mice by flushing femurs with complete medium (Dulbecco's modified Eagle medium, 10% fetal bovine serum) and dissociated by passage through a 22G needle. After red blood cell lysis, 2 3 10 6 bone marrow cells were injected intravenously into irradiated (1000 rads) recipient mice. B16 tumors were grown in recipient mice .4 weeks after transplant.
Results

Investigation of the b3/kindlin-2 interaction
Because specific regions of the b3 tail may support its interaction with 1 or more intracellular proteins, [38] [39] [40] we sought to establish a means to evaluate the selective interaction of kindlin-2 with b3 in the context of integrin aVb3. Therefore, affinity chromatography 27, 28, 31 was used to identify mutant b3 tails that would enable selective study of the b3/kindlin-2 interaction ( Figure 1A ). Unlike the WT b3 tail that bound kindlin-2 and c-Src, a b3DRGT tail lacking the C-terminal RGT sequence did not bind c-Src and bound little kindlin-2 ( Figure 1B-C) .
In contrast, the b3/b1(EGK) tail, where RGT was replaced by the corresponding residues in b1 (Glu-Gly-Lys), 13 retained the ability to bind kindlin-2, but bound little if any c-Src ( Figure 1B -C). All these b3 tails bound talin, which interacts with more membrane-proximal b3 tail residues. 8, 39, 40 Thus, we reasoned that a comparison of aVb3 function in the context of the b3DRGT tail vs the b3/b1(EGK) tail would allow a determination of the selective role of the b3/kindlin-2 interaction in cells.
Disruption of the b3/kindlin-2 interaction impairs aVb3-dependent cellular functions
Primary murine lung ECs (LECs) from b3 WT, and b3DRGT homozygous and b3/b1(EGK) homozygous mice were isolated. 13 Surface expression of b3 in b3DRGT LECs was ;50% of that in b3 1/1 LECs and similar to b3 expression in b3 1/2 LECs. b3/b1(EGK) LECs expressed ;80% the level of b3 in b3 1/1 LECs (supplemental Figure 1A ). Unlike the elevated expression of VEGFR-2 in ECs from b3 2/2 mice, 5 VEGFR-2 expression was normal in b3DRGT ECs. Moreover, VEGF-induced tyrosine phosphorylation of VEGFR-2 and serine-threonine phosphorylation of its downstream target, ERK1/2, were normal in b3DRGT ECs (supplemental Figure 1B) .
To obtain unlimited quantities of ECs for further study, LECs were immortalized 41 and single colonies were selected. imLECs grew well in culture at the permissive temperature of 33°C and displayed an EC morphology at 37°C (supplemental Figure 2A ). Surface expression of b3 and aV was similar in b3DRGT and b3 1/1 imLECs (supplemental Figure 2B ). Because aVb3 promotes EC migration, 42 we tested whether the deletion or substitution of b3 RGT affected migration in a chemotactic Transwell assay. Compared with b3 1/1 imLECs, b3DRGT imLECs showed reduced migration across vitronectin in the presence of a serum gradient (P , .05) ( Figure 2A ). In contrast, migration of b3/b1(EGK) imLECs was similar to that of b3 1/1 imLECs ( Figure 2B ). b3DRGT imLECs also showed reduced migration across another matrix ligand for aVb3 (fibrinogen), but not across collagen, a ligand for certain b1 integrins (not shown). Thus, the b3 tail C terminus promotes aVb3-dependent EC migration in a manner that likely requires b3 tail interaction with kindlin-2, the only kindlin isoform we could detect in these cells by western blotting.
When ECs are cultured on microcarrier beads in a 3-dimensional fibrin matrix, they extend sprouts analogous to those formed by ECs during angiogenesis. 34, 43 In this system, b3 1/1 imLECs started sprouting from beads within 1 day, and sprouts continued to elongate for up to 72 hours ( Figure 2C -D). Sprout formation in fibrin could be blocked by cilengitide, an inhibitor of aVb3 and aVb5, 44 suggesting that this process is dependent on aVb3 under these experimental conditions. Significantly fewer sprouts were observed at 24 and 48 hours from beads coated with b3DRGT imLECs (P , .05) ( Figure 2C ,E), whereas b3/b1(EGK) imLECs formed sprouts normally ( Figure 2D ,F). Similar results were obtained with primary b3DRGT ECs (supplemental Figure 3) . Thus, the C terminus of the b3 cytoplasmic tail promotes EC sprouting in a manner that likely requires tail interaction with kindlin-2.
To provide direct evidence that a proximal interaction between kindlin-2 and b3 promotes EC sprout formation, a heterodimerizer system was used to enforce this interaction in imLECs expressing b3DRGT. Following short hairpin RNA (shRNA) knock-down of endogenous aV, b3DRGT or b3 1/1 imLECs were engineered to stably coexpress human aV and kindlin-2 fusion proteins designed to heterodimerize upon addition of a small molecule, AP21967 45, 46 ( Figure 3A) . Expression of the fusion proteins was similar in b3DRGT and b3 1/1 imLECs (supplemental Figure 4) . Incubation of the b3DRGT cells with AP21967 caused a significant increase in sprouting (P , .05) that by day 2 was similar to the level observed in control b3 1/1 imLECs that had not been exposed to AP21967 ( Figure 3B ). Thus conditional, enforced interaction between kindlin-2 and aVb3DRGT rescues angiogenic sprouting by ECs.
Kindlin-2, but not c-Src, promotes sprout formation by ECs
To establish directly whether kindlin-2 and/or c-Src is required for EC sprouting, shRNAs were used to knock down each of these proteins in b3 1/1 imLECs. Knock-down was achieved with each of 2 kindlin-2 shRNAs and 1 c-Src shRNA, but not with a control, scrambled shRNA ( Figure 4A ). Knock-down of kindlin-2 blocked angiogenic sprout formation by b3 1/1 imLECs ( Figure 4B, upper  panel) , an effect that was rescued by coexpression of shRNAresistant human kindlin-2 ( Figure 4C-E) . In contrast, knock-down of c-Src in b3 1/1 imLECs had no effect on sprout formation ( Figure 4B, lower panel) , nor did incubation of cells with SFK inhibitors, PP1 or PP2 (not shown). Moreover, when b3 1/1 imLECs depleted of kindlin-2 were used to express a human kindlin-2 mutant (Gln 614 → Ala; Trp 615 → Ala) with reduced binding to b3, 11, 47 angiogenic sprout formation failed to be rescued ( Figure 4C-E) .
These results establish that the binding of both kindlin-2 and c-Src to b3 requires an intact b3 tail C terminus, but only the former interaction promotes EC sprout formation.
The b3/kindlin-2 interaction appears dispensable for inside-out activation of aVb3 aVb3 is responsive to inside-out signals that lead to aVb3 activation and extracellular ligand binding. 48 We wondered if the C terminus of b3 was required for this process in ECs. imLECs were stimulated briefly with the protein kinase C activator, PDBu, and activation of aVb3 was monitored with WOW-1 Fab. 32, 33 Incubation of b3DRGT imLECs with PDBu led to an approximately 2-fold increase in specific WOW-1 Fab binding, a response similar to that observed with b3 1/1 imLECs ( Figure 5A ). When imLECs were plated on fibrinogen-coated coverslips and examined by confocal microscopy, WOW-1 Fab binding was observed at protrusive edges of cells expressing either b3DRGT or b3 1/1 (Figure 5B) . Thus, the C-terminal 3 amino acids of b3, and by extrapolation the binding of kindlin-2 to b3, may not be required to initiate activation of aVb3 in ECs, suggesting rather that they promote outside-in aVb3 signaling.
Role of the integrin b3/kindlin-2 interaction in vivo
One example of EC function in vivo is angiogenesis. Retinal angiogenesis occurs postnatally in the mouse. 49 When compared with Figure 6A-B) , whereas radial expansion was normal by day 7. In contrast, retinal angiogenesis in b3/b1(EGK) homozygous ( Figure 6C -D) and b3 1/2 pups was similar to that of b3 1/1 pups. Thus, the C-terminal 3 residues of b3, and by extrapolation the interaction of b3 with kindlin-2, are required for the normal pace of vascular development in the retina. This interpretation is consistent with the reported role of kindlin-2 in developmental angiogenesis in zebrafish and mice. 25 The migration of a specific group of ECs called tip cells helps to provide guidance during vascular development. 50 We assessed EC growth patterning at the vascular front of the developing retina, with particular attention to tip cell proliferation, tip cell numbers, and filopodia formation (supplemental Figure 5A-B) . b3DRGT retinas showed reduced tip cell numbers (16.5% reduction; P , .05) ( Figure 6E ) and filopodia density (29.8% reduction; P , .01) ( Figure 6F ), compared with b3 1/1 littermates. In addition, proliferation at the vascular front, taken as the number of Ki67-positive ECs, was reduced by 38.2% in b3DRGT retinas (P , .01) ( Figure 6I ). Tip cell numbers and filopodia formation were normal in b3/b1(EGK) retinas, (Figure 6G -H) and EC proliferation was even somewhat increased compared with b3 1/1 littermates (P , .05) ( Figure 6J ). Although aVb3 is expressed in vascular cells other than ECs, these results when taken together with the EC studies in vitro point to a role for the b3/kindlin-2 interaction in developmental angiogenesis.
To investigate aVb3 function in tumor angiogenesis, b3 mutant mice were injected subcutaneously with 2 3 10 5 B16F1 murine melanoma cells and tumors were evaluated 21 days later. 5, 51 b3DRGT homozygous mice showed reduced tumor weights (1.24 6 0.19 g, n 5 20) compared with b3 1/1 (2.23 6 0.34 g, n 5 19; P , .01) or b3 1/2 littermates (3.26 6 0.59 g, n 5 21; P , .01) ( Figure 7A) . Tumor blood vessel density, assessed by staining tumors with an antibody to CD31, was also reduced in tumors from b3DRGT mice compared with those from b3 1/1 or b3 1/2 mice ( Figure 7B ; supplemental Figure 5C ). In contrast, tumor weights and tumor vessel density in b3/b1(EGK) homozygous mice were similar to those in b3 1/1 littermates ( Figure 7C -D; supplemental Figure 5C ). Thus, the extreme C terminus of b3 and its interaction with kindlin-2 promote aVb3-dependent developmental and pathological angiogenesis.
Signaling from bone marrow-derived cells can contribute to pathological angiogenesis in mouse model systems. [52] [53] [54] To determine the role of bone marrow-derived cells, tumor growth was examined in mice transplanted with bone marrow from b3 1/1 or b3DRGT homozygous mice. When compared with B16 tumor growth in b3 1/1 mice transplanted with b3 1/1 bone marrow, tumor growth in b3DRGT mice transplanted with b3 1/1 bone marrow was reduced (P , .05) ( Figure 7E ). In contrast, tumor growth in b3 1/1 mice transplanted with b3DRGT bone marrow was similar to that observed in b3 1/1 mice transplanted with b3 1/1 bone marrow (P 5 .84) ( Figure 7E ). These results suggest that the defects in angiogenesis observed in b3DRGT mice are not dictated primarily by mutant b3 in bone marrow-derived cells. Rather, they are consistent with a role for mutant b3 in ECs.
Discussion
The mechanisms whereby bidirectional integrin signaling by aVb3 regulate cellular functions through interacting proteins, such as talin, kindlins, and SFKs remain incompletely understood. Although aVb3 is recognized to regulate angiogenesis in murine models, conclusions about its precise role have seemed contradictory. 7, 11, [17] [18] [19] [20] [21] Interpretation of aVb3 function in genetargeted mice may be limited in some cases because embryonic lethality, 19, 55 developmental compensation, 5 gene function redundancy, 56 or a requirement for the precise experimental control of timing and length of genetic manipulation. 6 Furthermore, although direct interactions of the b3 cytoplasmic tail with intracellular proteins are important for integrin signaling, 8, [38] [39] [40] interaction with aVb3 is unlikely the only manner in which these proteins regulate cellular functions. Here we sought to clarify the role of the b3 tail interaction with kindlin-2 in aVb3 signaling.
In pull-down assays, the WT b3 cytoplasmic tail interacted with kindlin-2 and c-Src, but the b3DRGT tail did not bind c-Src and bound little kindlin-2, and the b3/b1(EGK) tail interacted with kindlin-2 but not c-Src (Figure 1 ). Availability of b3DRGT and b3/b1(EGK) knock-in mice thus made it possible to evaluate the differential roles of b3/kindlin-2 and b3/c-Src interactions in vivo. The following major conclusions can be drawn: (1) Deletion of the b3 C-terminal 3 amino acids (R 760 GT 762 ) disrupts binding of Although these studies do not formally exclude a role for other b3-expressing vascular cells in the angiogenesis phenotypes observed in b3DRGT mice, they extend previous work on integrins, SFKs, and kindlin-2 in ECs, 25, 56, 57 and they provide a mechanistic context for kindlin-2 in aVb3 outside-in signaling. Kindlin-2 enhances talin-dependent activation of platelet integrin aIIbb3 in a CHO cell expression system. 11, 19 We did not detect an impairment in the binding of activation-dependent antibody, WOW-1 Fab, to aVb3DRGT ECs ( Figure 5 ). This suggests that a direct interaction between kindlin-2 and b3 is not absolutely required for inside-out aVb3 signaling. This conclusion may seem at odds with studies of platelets deficient in kindlin-3, which do not bind fibrinogen normally in response to agonists. 22, 23, 58 However, agonist-induced fibrinogen binding to aIIbb3 in b3DRGT murine platelets is only minimally impaired, 13 and similar observations were made in knock-in platelets expressing a b3 integrin binding-defective kindlin-3 mutant. 59 WOW-1 Fab binding to b3(DiY.F) ECs stimulated by VEGF is reportedly impaired. 7 However, unlike aVb3DRGT, interactions of b3(DiY.F) with both talin and kindlin-2 are likely to be impaired.
Given normal WOW-1 Fab binding to aVb3DRGT ECs, their reduced spreading on vitronectin (supplemental Figure 2C) suggests a predominant role for the b3/kindlin-2 interaction in outside-in aVb3 signaling.
Although SFKs have been shown to play a role in VEGFinduced angiogenesis, 34, 57 we found that mice expressing b3/b1 (EGK), which cannot bind c-Src, exhibit normal retinal and tumor angiogenesis ( Figures 6 and 7) . Moreover, c-Src knockdown ( Figure 4 ) or SFK inhibition failed to prevent EC sprouting in vitro. This is consistent with previous studies showing that c-Src knockout mice exhibit tumor growth and angiogenesis equivalent to c-Src replete controls, 53 and that c-Src or Yes Figure 5 . Deletion of RGT from the b3 cytoplasmic tail does not impair activation of endothelial cell aVb3. (A) Immortalized lung endothelial cells were incubated for 30 minutes at room temperature with WOW-1 Fab in the presence or absence of 200 nM PDBu (to activate protein kinase C) or with 5 mM EDTA (to inhibit specific WOW-1 Fab binding). WOW-1 Fab binding was measured by flow cytometry as described in "Methods." Data represent specific WOW-1 Fab binding, defined as binding inhibited by EDTA, and represent means 6 SEM of 3 independent experiments. **P , .01; *P , .05; NS, not significant (paired Student t test). (B) Localization of activated aVb3 at lamellipodial edges. Cells were plated onto coverslips coated with fibrinogen and allowed to spread for 1 hour in the presence or absence of 200 nM PDBu as indicated. Cells were fixed, permeabilized, and stained with WOW-1 Fab, with antibody to total b3, and with phalloidin for F-actin as described in "Methods." Bar represent 30 mm.
BLOOD, 19 MARCH 2015 x VOLUME 125, NUMBER 12 aVb3/KINDLIN-2 INTERACTION AND INTEGRIN SIGNALING knock-down fails to affect VEGF-induced EC tube formation. 60 We suggest that b3/b1(EGK) ECs retain angiogenesis-related aVb3-dependent functions because the b3/b1(EGK) cytoplasmic tail can still interact with kindlin-2. Unlike the WT or b3/b1(EGK) cytoplasmic tails, the b3DRGT cytoplasmic tail cannot bind kindlin-2 (Figure 1 ). Our preliminary studies show that the same is true for kindlin-3, which unlike kindlin-2, is highly expressed in platelets. This may help to explain previous findings that b3DRGT mice, but not b3/b1(EGK) mice, show impaired platelet thrombus formation in a carotid artery injury model. 13 It is consistent with the observation that knock-in mice expressing a kindlin-3 mutant with impaired binding to b3 exhibit reduced thrombus formation. 59 Expression of kindlin-3 has been reported in some types of human ECs 61 ; however, we could not detect it by western blotting in the murine ECs used here.
RGD-based small-molecule antagonists or antibodies to aVb3 and other integrins are being evaluated in clinical trials for inflammatory and neoplastic disorders. 62, 63 Our results suggest that were selective disruption of the aVb3/kindlin-2 interaction possible, it might offer an alternative pharmacological approach by which to interfere with pathological processes dependent on this interaction. Inhibition of integrin cytoplasmic tail-protein interactions in cells is feasible. Su et al showed that a synthetic cell-permeable RGT peptide corresponding to the last 3 amino acids of b3 inhibits platelet function ex vivo. 64 The present studies suggest that this peptide might block both b3/kindlin-2 and b3/ c-Src interactions. For translational purposes, selective blockade Figure 6 . Postnatal retinal angiogenesis is delayed in b3DRGT mice, but not in b3/b1(EGK) mice. Retinas on postnatal day 3 (P3) from b3 1/1 and the indicated b3 mutant littermates were stained with anti-CD31 (to mark blood vessels) (A-D) or with fluorescein isothiocyanate-isolectin B4 (for vessels) and anti-Ki67 (for cell proliferation) (E-J) (supplemental Figure 5) , and cells were imaged as described in "Methods." (A,C) Representative images of whole mount retinas with 310 oil-dipping objective. Bar represents 500 mm. of the b3 tail interaction with kindlin-2 in ECs or with kindlin-3 in platelets would be required. Initial structural analyses of the b3 tail in complex with the c-Src SH3 domain have been conducted. 65 Analogous studies of the b3 tail in complex with kindlins could shed more light on the feasibility of such a therapeutic approach. Figure 7 . Tumor growth and tumor vessel density are reduced in b3DRGT mice, but not in b3/b1 (EGK) mice. b3 1/1 , b3 1/2 , and b3 mutant mice were inoculated subcutaneously with 300 mL of 2 3 10 5 B16F1 melanoma cells. (A,C) Quantification of tumor weights 21 days after inoculation. (B,D) Quantification of CD31-positive vessels per field in tumor sections as described in "Methods" (also see supplemental Figure  5C ). (E) b3 1/1 or b3DRGT mice were transplanted with the indicated bone marrow cells. There were 9-10 transplant recipients/group. Four to 6 weeks later, mice were inoculated with tumor cells and tumor weights were quantified 21 days after inoculation. Data represent means 6 SEM. *P , .05; **P , .01; NS, not significant (unpaired Student t test).
